The acquisition is intended to enable ResMed to improve its presence in the field of digital health for chronic obstructive pulmonary disorder (COPD) and enhance the market for Propeller Health’s solutions.
Propeller will function as a standalone entity within the respiratory care portfolio of ResMed upon completion of the transaction.
ResMed is a medical equipment company, while Propeller Health is a medical technology firm. Both companies are based in the US.
Generex Biotechnology has entered a letter of intent to acquire a majority stake of 51% in Olaregen Therapeutix .
Generex has paid $400,000 as initial payment for the acquisition, which is set to expand the medical device portfolio of the company.
Generex is based in Canada, while Olaregen is based in the US. Both are biotechnology companies.
Smith & Nephew has agreed to acquire Ceterix Orthopaedics .
The company will pay $50m in cash and up to $55m over the next five years based on financial performance.
The acquisition is expected to strengthen the meniscal repair portfolio of Smith & Nephew.
Smith & Nephew is a medical equipment company based in the UK, while Ceterix, also a medical equipment company, is based in the US.
The acquisition is expected to boost Conmed’s general surgery portfolio and strengthen its position in the smoke evacuation market.
Conmed is a developer of surgical devices for minimally-invasive procedures, while Buffalo Filter is a developer of surgical smoke evacuation technologies.
Both companies involved in the transaction are medical device companies based in the US.
The acquisition is expected to expand the market reach of Bruker, while meeting the customer requirements and increasing its customer base.
Bruker is a medical device company based in the US, while Alicona Imaging is a medical device supplier based in Austria.